Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vestbo (Manchester, United Kingdom). Is there a need for pharmacoepidemiology in asthma and COPD?. Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials

Member's Comments

No comment yet.

Related content which might interest you: What is COPD? What is asthma? Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 What is new in paediatric asthma? Source: Annual Congress 2006 - Paediatric year in review Year: 2006 Is it more than just asthma? Source: Virtual Congress 2020 – Paediatric respiratory diseases Year: 2020 Are we really transforming asthma and COPD management with biologics? Source: International Congress 2018 – State of the art session: Airways disease Year: 2018 Challenges in COPD exacerbations and future research and unknowns Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 Selfmanagement by eHealth in asthma and COPD patients: with or without the professional. Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020 Year: 2021 Do we need new therapies for noneosinophilic asthma? Source: Annual Congress 2004 - Noneosinophilic asthma Year: 2004 The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Comorbidities – should we and how should we treat them in asthma and COPD? Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014 Is it time to give up on “self-management” of COPD exacerbations? Source: Eur Respir J, 55 (1) 1902102; 10.1183/13993003.02102-2019 Year: 2020 Telehealthcare in COPD – A feasibility trial Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 Current opinion: Pharmacological approaches in asthma and COPD Source: Breathe 2009; 6: 24-35 Year: 2009 Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations? Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics Year: 2017 Defining acute asthma severity – how do worldwide asthma guidelines compare? Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations Year: 2018 Emergency visits for asthma: asthma exacerbations or poor asthma control? Source: Eur Respir J 2004; 24: Suppl. 48, 598s Year: 2004